Skip to main content

Table 1 Characteristics of the overall study population

From: Aspiration biopsy versus dilatation and curettage for endometrial hyperplasia prior to hysterectomy

Characteristics

n (%)

Age, years

49.0 ± 6.5

BMIa, kg/m2

24.8 ± 4.6

Parity

1.8 ± 0.7

Menopause

40 (16.0)

Diabetes

9 (3.6)

Hypertension

35 (14.0)

Tamoxifen

21 (8.4)

Abnormal uterine bleeding

154 (61.6)

EM sampling method

 D&C

100 (40.0)

 Aspiration biopsy

150 (60.0)

Time interval between EM sampling & hysterectomy, months

1.6 ± 1.0

EM sampling pathology

 SH

76 (30.4)

 CH

42 (16.8)

 SAH

4 (1.6)

 CAH

128 (51.2)

Hysterectomy pathology

 Normal

35 (14.0)

 SH

68 (27.2)

 CH

24 (9.6)

 SAH

3 (1.2)

 CAH

64 (25.6)

 Carcinoma

56 (22.4)

  1. Data are mean ± SD or n (%) unless otherwise specifiedik
  2. aBMI data are missing for two patients
  3. BMI Body mass index; EM Endometrial; D&C Dilatation and curettage; SH Simple hyperplasia without atypia; CH Complex hyperplasia without atypia; SAH Simple atypical hyperplasia; CAH Complex atypical hyperplasia